145 related articles for article (PubMed ID: 19485197)
1. Development and application of a high-performance liquid chromatographic method for the determination of in vitro drug release of levodopa, carbidopa, and entacapone from a tablet formulation.
Doshi AS; Upadhyay KJ; Mehta TN; Nanda N
J AOAC Int; 2009; 92(2):394-403. PubMed ID: 19485197
[TBL] [Abstract][Full Text] [Related]
2. Improved Bioavailability of Levodopa Using Floatable Spray-Coated Microcapsules for the Management of Parkinson's Disease.
Baek JS; Tee JK; Pang YY; Tan EY; Lim KL; Ho HK; Loo SCJ
Neuromolecular Med; 2018 Jun; 20(2):262-270. PubMed ID: 29696585
[TBL] [Abstract][Full Text] [Related]
3. Development and Validation of a Robust and Efficient HPLC Method for the Simultaneous Quantification of Levodopa, Carbidopa, Benserazide and Entacapone in Complex Matrices.
Wollmer E; Klein S
J Pharm Pharm Sci; 2017; 20(0):258-269. PubMed ID: 28810948
[TBL] [Abstract][Full Text] [Related]
4. A rapid liquid chromatography/tandem mass spectrometry method for simultaneous determination of levodopa, carbidopa, entacapone and their six related compounds in film-coated tablets.
Burmaoğlu RE; Sağlık Aslan S
Rapid Commun Mass Spectrom; 2020 Jun; 34(12):e8782. PubMed ID: 32170976
[TBL] [Abstract][Full Text] [Related]
5. LC determination of entacapone in tablets: in vitro dissolution studies.
Paim CS; Martins MT; Malesuik MD; Steppe M
J Chromatogr Sci; 2010 Oct; 48(9):755-9. PubMed ID: 20875238
[TBL] [Abstract][Full Text] [Related]
6. Levodopa/carbidopa/entacapone (Stalevo).
Hauser RA
Neurology; 2004 Jan; 62(1 Suppl 1):S64-71. PubMed ID: 14718682
[TBL] [Abstract][Full Text] [Related]
7. Comparison of 200 mg retarded release levodopa/carbidopa - with 150 mg levodopa/carbidopa/entacapone application: pharmacokinetics and efficacy in patients with Parkinson's disease.
Müller T; Ander L; Kolf K; Woitalla D; Muhlack S
J Neural Transm (Vienna); 2007; 114(11):1457-62. PubMed ID: 17564755
[TBL] [Abstract][Full Text] [Related]
8. Micellar HPLC-UV method for the simultaneous determination of levodopa, carbidopa and entacapone in pharmaceuticals and human plasma.
Belal F; Ibrahim F; Sheribah ZA; Alaa H
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1091():36-45. PubMed ID: 29843067
[TBL] [Abstract][Full Text] [Related]
9. Determination of L-dopa, carbidopa, 3-O-methyldopa and entacapone in human plasma by HPLC-ED.
Bugamelli F; Marcheselli C; Barba E; Raggi MA
J Pharm Biomed Anal; 2011 Feb; 54(3):562-7. PubMed ID: 21035976
[TBL] [Abstract][Full Text] [Related]
10. Investigation of different spectrophotometric and chemometric methods for determination of entacapone, levodopa and carbidopa in ternary mixture.
Abdel-Ghany MF; Hussein LA; Ayad MF; Youssef MM
Spectrochim Acta A Mol Biomol Spectrosc; 2017 Jan; 171():236-245. PubMed ID: 27541796
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the pharmacokinetics of an oral extended-release capsule formulation of carbidopa-levodopa (IPX066) with immediate-release carbidopa-levodopa (Sinemet(®)), sustained-release carbidopa-levodopa (Sinemet(®) CR), and carbidopa-levodopa-entacapone (Stalevo(®)).
Hsu A; Yao HM; Gupta S; Modi NB
J Clin Pharmacol; 2015 Sep; 55(9):995-1003. PubMed ID: 25855267
[TBL] [Abstract][Full Text] [Related]
12. Adherence with levodopa/carbidopa/entacapone versus levodopa/carbidopa and entacapone as separate tablets in patients with Parkinson's disease.
Delea TE; Thomas SK; Hagiwara M; Mancione L
Curr Med Res Opin; 2010 Jul; 26(7):1543-52. PubMed ID: 20429819
[TBL] [Abstract][Full Text] [Related]
13. Comparison of pharmacokinetic profile of levodopa throughout the day between levodopa/carbidopa/entacapone and levodopa/carbidopa when administered four or five times daily.
Kuoppamäki M; Korpela K; Marttila R; Kaasinen V; Hartikainen P; Lyytinen J; Kaakkola S; Hänninen J; Löyttyniemi E; Kailajärvi M; Ruokoniemi P; Ellmén J
Eur J Clin Pharmacol; 2009 May; 65(5):443-55. PubMed ID: 19229530
[TBL] [Abstract][Full Text] [Related]
14. [Optimization of use of levodopa in Parkinson's disease: role of levodopa-carbidopa-entacapone combination].
Castro A; Valldeoriola F; Linazasoro G; Rodriguez-Oroz MC; Stochi F; Marin C; Rodriguez M; Vaamonde J; Jenner P; Alvarez L; Pavon N; Macias R; Luquin MR; Hernandez B; Grandas F; Gimenez-Roldan S; Tolosa E; Obeso JA
Neurologia; 2005 May; 20(4):180-8. PubMed ID: 15891947
[TBL] [Abstract][Full Text] [Related]
15. Levodopa-entacapone-carbidopa intestinal gel in Parkinson's disease: A randomized crossover study.
Senek M; Nielsen EI; Nyholm D
Mov Disord; 2017 Feb; 32(2):283-286. PubMed ID: 27987231
[TBL] [Abstract][Full Text] [Related]
16. Pharmaceutical design and development of a Sinemet controlled-release formulation.
Dempski RE; Scholtz EC; Oberholtzer ER; Yeh KC
Neurology; 1989 Nov; 39(11 Suppl 2):20-4. PubMed ID: 2685648
[TBL] [Abstract][Full Text] [Related]
17. Frequent administration of levodopa/carbidopa microtablets vs levodopa/carbidopa/entacapone in healthy volunteers.
Nyholm D; Ehrnebo M; Lewander T; Trolin CG; Bäckström T; Panagiotidis G; Spira J; Nyström C; Aquilonius SM
Acta Neurol Scand; 2013 Feb; 127(2):124-32. PubMed ID: 22762460
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous estimation of levodopa and carbidopa by RP-HPLC using a fluorescence detector: its application to a pharmaceutical dosage form.
Raut PP; Charde SY
Luminescence; 2014 Nov; 29(7):762-71. PubMed ID: 24399763
[TBL] [Abstract][Full Text] [Related]
19. Night-time bioavailability of levodopa/carbidopa/entacapone is higher compared to controlled-release levodopa/carbidopa.
Kuoppamäki M; Sauramo A; Korpela K; Vahteristo M; Kailajärvi M; Lehtinen T; Ellmén J
Int J Clin Pharmacol Ther; 2010 Nov; 48(11):756-60. PubMed ID: 20979935
[TBL] [Abstract][Full Text] [Related]
20. Immediate versus delayed switch from levodopa/carbidopa to levodopa/carbidopa/entacapone: effects on motor function and quality of life in patients with Parkinson's disease with end-of-dose wearing off.
Lew MF; Somogyi M; McCague K; Welsh M;
Int J Neurosci; 2011 Nov; 121(11):605-13. PubMed ID: 21843110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
